Maider Medical Industry Equipment Co Ltd

Maider Medical Industry Equipment Co. Ltd. researches, develops, produces, sells, and services intelligent equipment for medical consumables in China and internationally. Its offerings include safety infusion equipment, such as self-destructing safety and insulin syringes; safety injection, indwelling, insulin, blood collection, and mini safety blood collection needles; central venous catheters; and infusion sets. The company also provides blood purification solutions, including automatic assembly machines for hemodialyzers, AV fistula needles, hemoperfusion cartridges, flushing syringes, dialysis bloodlines, peritoneal dialysis, and powder barrels; automatic spinning machines for hollow fiber membranes; and infusion solution equipment, such as automatic assembly machines for IV catheters and sets, and enteral feeding sets. In addition, it offers automatic assembly machines for aesthetic injection needles, pre-filled syringes, disposable transfusion sets, blood transfusion bags, leukocyte filters, membrane oxygenators, suction catheters, inhalers, nasal cannulas, biopsy needles, urinary catheters and bags, vacuum blood collection devices, disposable pump extension tubing, disposable spinal anesthesia needles, insulin pen needles and syringes, CGM components, immunology and biochemical reagents, vials, and cartridges. It further provides packaging solutions, including automatic packaging for cartoning and case packing, cable ties, bagged products, and blister packaging, and engages in wholesale activity. Founded in 2003, the company is headquartered in Taizhou, China.

688310.CG▼5

Maider Medical swings to loss in 2026 interim report with net profit of negative 16.36 million yuan

Maider Medical released its 2026 interim report, showing a swing from profit to loss. Net profit attributable to the parent company was negative 16.36 million yuan, a decrease of 22.41 million yuan compared with the same period last year, down 370.68 percent year on year. Total operating revenue was 160 million yuan. Net cash flow from operating activities was negative 17.55 million yuan, down 115.50 percent year on year. The company's asset-liability ratio was 28.33 percent, gross margin was 36.65 percent, return on equity was negative 2.11 percent, and diluted earnings per share was negative 0.10 yuan. The number of shareholders was 4,572, and the top ten shareholders held 73.41 percent of the total share capital.

688310.CG ▼

Jiemian·24dRead more →